What if periodontal aftercare could add a protective layer—without adding another drug to the treatment protocol? A new development in periodontal care is gaining attention as Premier Dental Products Company expands U.S. access to PerioStōm, an FDA-cleared, non-drug oral wound dressing developed by Forward Science.
What is PerioStōm?
PerioStōm is designed for post-procedural periodontal care, particularly following procedures such as scaling and root planing (SRP).
Its key component is chitosan microspheres, a biocompatible polymer. When placed directly into the periodontal pocket, the material forms a protective, bio-adhesive barrier intended to help shield vulnerable tissues from irritation and trauma while supporting gingival healing and patient comfort.
For clinicians, the interesting aspect isn’t simply the material—it’s how easily the concept fits into existing periodontal workflows.
PerioStōm is designed to:
- Provide localized post-procedural protection
- Support gingival healing and patient comfort
- Form a bio-adhesive barrier within the periodontal pocket
- Integrate with established periodontal treatment protocols
- Offer a non-drug approach to post-procedural care
- Provide consistent placement through its delivery system
Beyond SRP: Rethinking the Healing Phase
Periodontal treatment is often discussed in terms of diagnosis, instrumentation and removal of pathogenic deposits. But what happens after the procedure is equally important.
The healing environment can influence patient comfort, tissue recovery and the overall treatment experience.
This is where products such as PerioStōm are attracting attention: rather than replacing conventional periodontal therapy, the concept is to add another layer of post-procedural support.
A Shift Toward Localized Dental Care
The development also reflects a wider trend in dentistry toward localized, minimally invasive and workflow-friendly solutions.
PerioStōm is one example of this evolving approach.
PerioStōm isn’t positioned as a replacement for periodontal therapy. Instead, it represents an adjunctive approach focused on the post-procedural healing phase.
As always, clinicians should review the product’s official indications, instructions for use and available clinical evidence before incorporating any new product into patient care.
Reference
PerioStōm
